Clinical Trial

Sintilimab Plus Bevacizumab and Chemotherapy in MSS/pMMR Colorectal With no Liver Metastasis

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated May 15, 2025 (before its estimated February 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a non-randomized, open-label, single-center clinical trial to evaluate efficacy and safety of sintilimab plus bevacizumab and chemotherapy on treatment in patients with advanced no liver metastatic MSS/pMMR colorectal cancer
Trial Details
NCT Number NCT06973343
Lead Sponsor Anhui Provincial Cancer Hospital
Conditions Colorectal Cancer Metastatic
Enrollment 20 participants
Start Date 2025-05
Primary Completion 2026-02 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2025-05-15